Shares of Amneal Pharmaceuticals Inc plunged 36% to an all-time low on Wednesday after the generic drugmaker cut its 2019 core earnings forecast due to supply uncertainties related to its epinephrine auto-injectors.
Surgery patients who were taught to manage their pain with acetaminophen and ibuprofen ended up using few or no opioid pills, a recent study found.
The U.S. drug regulator on Friday approved Palatin Technologies and Amag Pharmaceuticals' drug to restore sexual desire in premenopausal women, the latest attempt to come up with a therapy that some have dubbed as "female Viagra".
(Reuters Health) - Flashing light effects that have become the norm for electronic dance music concerts could bring on epileptic seizures in young people who may not know they have a vulnerability, Dutch researchers say.
(Reuters Health) - Preventing falls among elderly patients who've just left the hospital is an important part of keeping them safe, a large U.S. study shows.
(Reuters Health) - More than three years after Pennsylvania issued a statewide order expanding access to the life-saving opioid antidote naloxone, the product was still hard to purchase in Philadelphia pharmacies, researchers found.
Enanta Pharmaceuticals Inc said on Friday its treatment for a highly contagious respiratory infection met the main goal of reducing virus levels in the body in a mid-stage study.
(Reuters Health) - More than three-quarters of antibiotic prescriptions written by dentists before dental procedures are unnecessary and might do more harm than good, a new U.S. study found.
Catalyst Pharmaceuticals Inc, which has come under fire for the high price tag on its rare disease drug, on Wednesday sued the U.S. Food and Drug Administration to challenge the recent approval of a lower-cost rival drug.
(Reuters Health) - Too little sleep - or too much - can be tied to problems with blood sugar levels, not just in people with diabetes but also in people at high risk for developing the disease, a new study finds.